T lymphocytes and gamma interferon (IFN-gamma) are known mediators of immun
e resistance to Toxoplasma gondii infection, but whether B cells also play
an important role is not clear. We have investigated this issue using B-cel
l-deficient (mu MT) mice. If vaccinated with attenuated T. gondii tachyzoit
es, mu MT mice are susceptible to a challenge intraperitoneal infection wit
h highly virulent tachyzoites that similarly vaccinated B-cell-sufficient m
ice resist. Susceptibility is evidenced by increased numbers of parasites a
t the challenge infection site and by extensive mortality. The susceptibili
ty of B-cell-deficient mice does not appear to be caused by deficient T-cel
l functions or diminished capacity of vaccinated and challenged B-cell-defi
cient mice to produce IFN-gamma. Administration of Toxoplasma-immune serum,
but not nonimmune serum, to vaccinated B-cell-deficient mice significantly
prolongs their survival after challenge with virulent tachyzoites. Vaccina
ted mice lacking Fe receptors or the fifth component of complement resist a
challenge infection, suggesting that neither Fc-receptor-dependent phagocy
tosis of antibody-coated tachyzoites nor antibody-dependent cellular cytoto
xicity nor antibody-and-complement-dependent lysis of tachyzoites is a cruc
ial mechanism of resistance. However, Toxoplasma-immune serum effectively i
nhibits the infection of host cells by tachyzoites in vitro. Together, the
results support the hypothesis that B cells are required for vaccination-in
duced resistance to virulent tachyzoites in order to produce antibodies and
that antibodies may function protectively in vivo by blacking infection of
host cells by tachyzoites.